Spain – Antineoplastic and immunomodulating agents – Medicamentos biológicos con biosimilares (AM INGESA 2021/064)
Servicio Cántabro de Salud awarded €346K to KERN PHARMA, S.L. for Construction & Public Works in February 2025 — one of 607 awards this buyer has made, above its typical award size.
Buying agency
Servicio Cántabro de SaludWinning supplier
KERN PHARMA, S.L.Contract description
Spain – Antineoplastic and immunomodulating agents – Medicamentos biológicos con biosimilares (AM INGESA 2021/064)
Related awards · Servicio Cántabro de Salud
607 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-568172-2024VIAS Y CONSTRUCCIONES S.A. - C. LASOR S.L.€19.5M20 Sep 2024 Construction
- ocds-ted-263493-2024Soemca Empleo, S.L.U.€15.7M03 May 2024 Professional Services
- ocds-ted-386252-2025OXIMESA, SLU€14.9M16 Jun 2025 Professional Services
Other wins · KERN PHARMA, S.L.
37 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-149649-2026-4Servicio Andaluz de Salud. Hospital Universitario Puerta del Mar€5.1M04 Mar 2026 Construction
- ocds-ted-424178-2024OSAKIDETZA - Servicio Vasco de Salud - Organización Central€1.4M16 Jul 2024 Construction
- ocds-ted-696051-2024Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria€561K15 Nov 2024 Construction
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Servicio Cántabro de Salud and KERN PHARMA, S.L. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back